The first detection of Jingmen tick virus (JMTV) in humans in Türkiye, 2022.


Öz M., Dinçer E., Pektaş A. N., Timurkan M. Ö., Bağcı B., Taşseten T. N., ...Daha Fazla

Pathogens and global health, ss.1-8, 2025 (SCI-Expanded, Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası:
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1080/20477724.2025.2603234
  • Dergi Adı: Pathogens and global health
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.1-8
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Jingmen tick virus (JMTV) is a single-stranded RNA virus transmitted to humans through tick bites and classified within the Flaviviridae family. It has been detected in various arthropods and mammals. JMTV causes an acute febrile illness with symptoms such as skin lesions, fatigue, headache, nausea, and vomiting; however, limited research exists on its clinical impact and pathogenesis in humans. This study aims to report the first detection and molecular characterization of JMTV in patients with Crimean-Congo Hemorrhagic Fever (CCHF) in Türkiye. During the 2022 outbreak, serum samples from 206 hospitalized CCHF-suspected patients were retrospectively analyzed. JMTV was identified in 3 (1.5%) cases using nested PCR. The nucleotide similarity within the three JMTV sequences was found to be between 98.0% and 99.0%. Phylogenetic analysis showed 82-98% similarity with previously identified JMTV isolates in Türkiye. This study presents the first detection and molecular characterization of JMTV in humans in Türkiye. Clinicians should consider JMTV in patients with a history of tick bites, especially in CCHF-endemic regions.